Papers

3

Total Citations

21

H-Index

2

About

Francesco Trevisani is a rising figure in urologic oncology, whose research bridges the critical gap between surgical outcomes and renal function. His work centers on the emerging field of onco-nephrology, investigating how major urologic surgeries impact kidney health. Trevisani’s most-cited study, a large retrospective analysis of 17 citations, comprehensively assessed how frailty status influences surgical, functional, and oncologic outcomes in patients undergoing partial nephrectomy, providing crucial data for preoperative risk stratification. He has further advanced this area by identifying predictors of acute kidney injury (AKI) and acute kidney disease (AKD) after robot-assisted radical prostatectomy and, in a landmark study of 840 patients, after radical cystectomy for muscle-invasive bladder cancer. By defining the incidence and risk factors for these renal complications, Trevisani’s work is shaping new clinical protocols to protect long-term kidney function in cancer survivors. His research offers a vital, patient-centered perspective, demonstrating that surgical success must be measured not only by cancer control but also by the preservation of renal health.

Research Focus

Key Achievements

2
H-Index
3
Papers
21
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy—A large, retrospective, single-center study
17 citations · 2022
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico, IRCCS Ospedale San Raffaele

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago